Study of Bronchiectasis and Associated Cardiovascular Comorbidities
NCT ID: NCT05783869
Last Updated: 2025-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
30 participants
OBSERVATIONAL
2023-03-25
2026-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchiectasis
NCT07289100
Prevalence of Bronchiectasis in COPD Patients
NCT04101448
Bronchiactasis as Atypical Presentation in COVID-19
NCT04910113
Early Detection of Pulmonary Exacerbations in Non-cystic Fibrosis Bronchiectasis
NCT06151366
Bronchial Asthma & Its Exacerbation
NCT06331897
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient with bronchiectasis and cardiovascular comorbidities
Patients with Bronchiectasis had no comorbidities other than cardiovascular comorbidities during the study period.
Echocardiography
echocardiographic study of both groups
Patients with bronchiectasis and without cardiovascular comorbidities
Patients with Bronchiectasis had no comorbidities.
Echocardiography
echocardiographic study of both groups
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Echocardiography
echocardiographic study of both groups
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Any other comorbidity or end-organ failure may affect the study's result.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aliae AR Mohamed Hussein [ahussein
UNKNOWN
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmad Shaddad
Lecturer of pulmonary medicine Assuit university
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmad Shaddad
Role: PRINCIPAL_INVESTIGATOR
Assuit University Faculty of Medicine
Ahmad Shaddad
Role: PRINCIPAL_INVESTIGATOR
Assiut University Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut unviresty - Faculty of Medicine
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23455668
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.